Hepatitis C Virus (HCV)-Specific Immune Responses of Long‐Term Injection Drug Users Frequently Exposed to HCV

E Mizukoshi, C Eisenbach, B Edlin, K Newton, S Raghuraman, C Weiler‐Normann, L Tobler, M Busch, M Carrington, Jane McKeating, T O’Brien, B Rehermann

Research output: Contribution to journalArticle

53 Citations (Scopus)
658 Downloads (Pure)


BACKGROUND: Injection drug users (IDUs) who successfully clear hepatitis C virus (HCV) have a reduced risk of developing chronic reinfection, despite their continuing exposure to the virus. To identify immunological correlates for this apparent protection, we studied HCV-specific immune responses in long-term IDUs (duration, >10 years). METHODS: HCV-specific T cell responses were assessed in proliferation, enzyme-linked immunospot (ELISPOT), interferon (IFN)-gamma secretion, and cytotoxicity assays, whereas HCV-specific antibodies were assessed in enzyme immunoassays (EIAs), chemiluminescent assays, and in vitro neutralization assays. RESULTS: HCV-specific T cell proliferation and IFN-gamma production were more common in nonviremic EIA-positive IDUs (16 [94%] of 17 IDUs) than in viremic EIA-positive IDUs (9 [45%] of 20 IDUs) (P= .003). They were also noted in 16 (62%) of 26 nonviremic EIA-negative IDUs. In contrast, 19 (90%) of 21 viremic IDUs displayed neutralizing antibodies (nAbs), compared with 9 (56%) of 16 nonviremic EIA-positive IDUs (P= .04) and 0 of 24 nonviremic EIA-negative IDUs. Nonviremic IDUs with nAbs were older (P= .0115) than those without nAbs, but these groups did not differ in terms of either injection drug use duration or HCV-specific T cell responses. CONCLUSION: The reduced risk of HCV persistence in IDUs previously recovered from HCV infection correlated with T cell responses, and prolonged antigenic stimulation appears to be required to maintain humoral responses.
Original languageEnglish
Pages (from-to)203-212
Number of pages10
JournalThe Journal of Infectious Diseases
Issue number2
Publication statusPublished - 15 Jul 2008


Dive into the research topics of 'Hepatitis C Virus (HCV)-Specific Immune Responses of Long‐Term Injection Drug Users Frequently Exposed to HCV'. Together they form a unique fingerprint.

Cite this